Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study

OBJECTIVE: Between 2012 and 2017, the U.S. Food and Drug Administration (FDA) approved 10 antidiabetic indicated therapies. Due to the limited literature on voluntarily reported safety outcomes for recently approved antidiabetic drugs, this study investigated adverse drug reactions (ADRs) reported i...

Descripción completa

Detalles Bibliográficos
Autores principales: Stottlemyer, Britney A., McDermott, Michael C., Minogue, Mackenzie R., Gray, Matthew P., Boyce, Richard D., Kane-Gill, Sandra L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272667/
https://www.ncbi.nlm.nih.gov/pubmed/37332887
http://dx.doi.org/10.1177/20420986231181334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272667/
https://www.ncbi.nlm.nih.gov/pubmed/37332887
http://dx.doi.org/10.1177/20420986231181334

Ejemplares similares